Growth Metrics

Avanos Medical (AVNS) Receivables (2016 - 2024)

Historic Receivables for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $137.3 million.

  • Avanos Medical's Receivables fell 544.08% to $137.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $137.3 million, marking a year-over-year decrease of 544.08%. This contributed to the annual value of $142.8 million for FY2023, which is 1494.94% down from last year.
  • As of Q3 2024, Avanos Medical's Receivables stood at $137.3 million, which was down 544.08% from $128.1 million recorded in Q2 2024.
  • In the past 5 years, Avanos Medical's Receivables registered a high of $186.5 million during Q3 2020, and its lowest value of $109.5 million during Q1 2021.
  • For the 5-year period, Avanos Medical's Receivables averaged around $143.8 million, with its median value being $142.8 million (2023).
  • As far as peak fluctuations go, Avanos Medical's Receivables plummeted by 3495.98% in 2021, and later soared by 4757.99% in 2022.
  • Avanos Medical's Receivables (Quarter) stood at $167.9 million in 2020, then dropped by 21.86% to $131.2 million in 2021, then grew by 27.97% to $167.9 million in 2022, then dropped by 14.95% to $142.8 million in 2023, then decreased by 3.85% to $137.3 million in 2024.
  • Its last three reported values are $137.3 million in Q3 2024, $128.1 million for Q2 2024, and $131.3 million during Q1 2024.